Brad Hively

Brad Hively

Vice Chairman of the BoardatStarling Oncology· In proxies 2022–2025

Pay in FY2023-82% from the year before · Starling Oncology stock +23.6% the same year

Brad Hively was paid $1.2M in FY2023 (Dec), down 82%. Starling Oncology stock rose 23.6% that year.

Pay$100 in the stock at the end of FY21 → $21
Pay is from the Summary Compensation Table of each Starling Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Starling OncologyPublic company · 4 yr
    • Vice Chairman of the Board2022 – Present · 4 yrStock in role -39%
  2. Sequel OrthoPublic company
    • Director? – PresentNo stock prices for these years
  3. US Neurology AssociatesPublic company
    • Director? – PresentNo stock prices for these years
  4. Unio Health PartnersPublic company
    • Director? – PresentNo stock prices for these years
  5. Vytal Health PartnersPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?